Skip to main content
. 2010 Jul 8;6(7):e1000988. doi: 10.1371/journal.ppat.1000988

Table 1. Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study.

species No lineage genotype RD9 TbD1 pks15/1 INH RMP PZA EMB SM
M. tuberculosis 9532/03 Euro-American Haarlem + s s s s s
2336/02 Euro-American Haarlem + s s s s s
4130/02 Euro-American Haarlem + s s s s s
2333/99 Euro-American Uganda + s s s s s
2169/99 Euro-American Uganda + s r s s s
2191/99 Euro-American Uganda + s s s s s
1934/03 East Asian Beijing + + s s s s s
1500/03 East Asian Beijing + + s s s s s
12594/02 East Asian Beijing + + s s s s s
4850/03 Indo Oceanic EAI + + + s s s s s
1797/03 Indo Oceanic EAI + + + s s s s s
947/01 Indo Oceanic EAI + + + s s s s s
M. africanum 10517/01 West-African 2 WA2 + s s s s s
5468/02 West-African 2 WA2 + s s s s s
10514/02 West-African 2 WA2 + r s s s s

Molecular genotyping and drug sensitivity testing of Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study. Strain lineages are based on phylogenetic analysis by Gagneux et al. [86]. TbD1, RD9 and pks15/1 denote the presence or absence of previously reported phylogenetic markers [87], [88]. The Euro-American strains (Haarlem and Uganda genotypes) contain a 7bp deletion and W. African 2 strains contain a 6bp deletion in pks15/1. Abbreviations: EAI (East African Indian), WA2 (West African 2), INH (isoniazid), RMP (rifampicin), EMB (ethambutol), PZA (pyrazinamide), SM (streptomycin), s (sensitive), r (resistant).